RLMD
Relmada Therapeutics Inc.
$2.26
-$0.06(-2.59%)
63
Overall
60
Value
66
Tech
--
Quality
Market Cap
$50.78M
Volume
54.78K
52W Range
$0.24 - $3.67
Target Price
$1.00
Key Metrics Overview
| Market Cap | $50.78M | P/E Ratio | NaN |
| 52W High | $3.67 | 52W Low | $0.24 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | 28.2% | 52W Position | 58.9% |
| Overall Score | 63 | Value Score | 60 |
| Quality Score | -- | Technical Score | 66 |
Growth Analysis
| EPS Current Est | $NA | EPS Next Est | $-0.05 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RLMD | $2.26 | -2.6% | 54.78K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Relmada Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW